Macquarie Group LTD Jazz Pharmaceuticals PLC Transaction History
Macquarie Group LTD
- $87.4 Billion
- Q1 2024
A detailed history of Macquarie Group LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Macquarie Group LTD holds 37,915 shares of JAZZ stock, worth $4.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,915
Previous 38,282
0.96%
Holding current value
$4.05 Million
Previous $4.71 Million
3.04%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57.1MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$755 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$688 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$263 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$254 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$160 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.69B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...